Please Login to read the full article.
Clinica
02 April 2009
Joseph Harvey
Please Login to read the full article.
Not a subscriber ? Request a FREE Trial
Subscribe to Clinica
RELATED CONTENT
NEWS
Clinica News
- Advantage to Boston in long-running DES patent dispute with J&J
- Heart stent firms may be hit by unfavourable study showing drugs as good – and cheaper – in stable patients
- J&J suffers knock-back in drug-eluting stent wars
- TCT 2011: Boston's next-gen Promus Element succeeds in long lesions; Ion beats older-gen stents
Other Informa News
EVENTS
